FDA panel backs GSK RSV vaccine ahead of approval
March 2, 2023Medical Communications
Yesterday, GSK shared that an advisory committee from the FDA voted in support of its respiratory syncytial virus (RSV) vaccine …
Menopause Action Plan – How nutritional support can keep female employees at work
March 1, 2023Business Services
Through simple nutrition and lifestyle changes HR managers could enable women to continue to thrive at work and pursue their …
Ten new companies enter BioInnovation Institute’s Venture Lab program
March 1, 2023Business Services
COPENHAGEN, Denmark, March 1, 2023 – BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, today …
Koa Health appoints Dr Anna Mandeville as UK Clinical Director and Leslie Norwalk to the Supervisory Board
March 1, 2023Business Services
London, 1st March 2023: Koa Health, a leading global provider of digital mental healthcare solutions, today announces that Dr Anna …
PureTech to Present at the Barclays Global Healthcare Conference
March 1, 2023Business Services
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment …
NICE recommends more digital mental health therapies for NHS use
March 1, 2023Medical Communications
Eight more digital therapies (DTx) for mental health disorders have been recommended by NICE for use by the NHS, following …
FDA approves Reata Pharmaceuticals’ first-in-class treatment for Friedreich’s Ataxia
March 1, 2023Medical Communications
US-based Reata Pharmaceuticals has announced that its first-in-class treatment for Friedreich’s Ataxia (FA), Skyclarys, has been given FDA approval. This …
BioNxt Solutions signs clinical study agreement and commences clinical samples manufacture for Parkinson’s disease trial
March 1, 2023Research and Development
BioNxt Solutions, a bioscience accelerator focused on next-generation drug formulations and delivery systems, has announced the finalisation of its comparative …
Sequana Medical shares positive results from phase 1 clinical trial
March 1, 2023Research and Development
Sequana Medical has shared positive results from its phase 1 trial, CHIHUAHUA, assessing the safety and tolerability of a single …
Industrywide Survey Reveals Centralising Regulatory is Number One Priority for Medtech
March 1, 2023Business Services
BARCELONA, Spain — 28 Feb. 2023 — New research shows a majority of medtech organizations are taking action to advance …
Ascelia Pharma meets major milestone with patient enrollment completion of Phase 3 Study for Orviglance, novel MRI contrast agent for patients with kidney impairment
February 28, 2023Business Services
Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, …
Johnson & Johnson’s Janssen-Cilag unit gets disappointing ‘restricted’ label for PARP drug in EU
February 28, 2023Medical Communications
Johnson & Johnson (J&J)’s Janssen-Cilag unit has announced that its fixed-dose combination drug Akeega has been recommended for approval by …
Moderna to pay $400m to US government over new COVID-19 vaccine license
February 28, 2023Sales and Marketing
Moderna, a leader in the development of COVID-19 vaccines, announced that it has paid the National Institute of Allergy and …
CSL receives positive results from rare disease drug phase 3 trial
February 28, 2023Research and Development
Biotech company CSL has reported positive results from its phase 3 trial for garadacimab, a monthly treatment for hereditary angioedema …
MHRA’s authority restored following Northern Ireland Brexit deal
February 28, 2023Medical Communications
The Medicines and Healthcare products Regulatory Agency (MHRA) has been limited to approving medicines in Great Britain (England, Scotland and …
Rare and orphan disease expert Terebellum launches market access guide
February 28, 2023Business Services
Terebellum, subsidiary of global specialty pharmacy and healthcare solutions organisation AscellaHealth, is launching a strategic guide to help manufacturers bring …
Rare disease community call for their unified voice to be heard in the fight for equitable care
February 28, 2023Business Services
Reading, 28th February 2023.
PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)
February 27, 2023Business Services
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …
Almirall opens the doors of its R&D centre to the biotech ZeClinics
February 27, 2023Business Services
BARCELONA, Spain. February 27th 2023 – Almirall, a global biopharmaceutical company focused on skin health, today announced an agreement with …
HUTCHMED Completes Patient Enrollment of Phase II Registration Trial of Amdizalisib in Follicular Lymphoma in China
February 27, 2023Business Services
Hong Kong, Shanghai & Florham Park, NJ — Monday, February 27, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM, HKEX:13) today announces …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
